Published 2022-06-01
“…Eloy A Zepeda-Carrillo,1,2,* Omar Ramos-Lopez,3 Erika Martínez-López,4 Elisa Barrón-Cabrera,5 J Antonio Bernal-Pérez,6 Luisa E Velasco-González,6 Ernesto Rangel-Rios,6 J Fausto Bustamante Martínez,2 Rafael Torres-Valadez1,7,* 1Specialized Unit in Research, Development and Innovation in Genomic Medicine, Nayarit Center for Innovation and Technology Transfer, Autonomous University of Nayarit,
Tepic, Nayarit, Mexico; 2Civil Hospital “Dr. Antonio González Guevara”, Health Services in Nayarit,
Tepic, Nayarit, Mexico; 3Medicine and Psychology School, Autonomous University of Baja California, Tijuana, B.C, Mexico; 4Institute of Translational Nutrigenetics and Nutrigenomics, Department of Molecular and Genomic Biology, University Center of Health Sciences, University of Guadalajara, Guadalajara, Jalisco, Mexico; 5Faculty of Nutrition and Gastronomy Sciences, Autonomous University of Sinaloa, Culiacan, Sinaloa, Mexico; 6Family Medicine Unit No. 24 “Ignacio García Téllez”, Mexican Social Security Institute,
Tepic, Nayarit, Mexico; 7Integral Health Academic Unit, Autonomous University of Nayarit,
Tepic, Nayarit, Mexico*These authors contributed equally to this workCorrespondence: Rafael Torres-Valadez, Nayarit Center for Innovation and Technology Transfer, Autonomous University of Nayarit,
Tepic, Nayarit, Mexico, Tel +52-3312523644, Email rafael.torres@uan.edu.mxPurpose: Differences in metformin effect on glycemic control in type 2 Diabetes (T2D) have been associated with diet, obesity, years since T2D diagnosis and genetic factors, such as the Met408Val (rs628031) SLC22A1/OCT1 gene polymorphism. …”
Get full text
Article